Senior Manager, GMP Quality Assurance at Structure Therapeutics | USA | Rezi

Senior Manager, GMP Quality Assurance at Structure Therapeutics

Senior Manager, GMP Quality Assurance

Structure Therapeutics · USA

1 months ago

Senior Manager, GMP Quality Assurance

Structure Therapeutics · USA

a month ago
Resume preview

Impress employers and recruiters.
Choose from hundreds of resume examples.

Target Resume Now

About the Role

The Senior Manager, Quality Assurance – Drug Product provides quality oversight for outsourced drug product manufacturing, packaging, labeling, testing, release, and distribution for clinical-stage and late-phase programs. This role serves as the primary QA representative for CDMOs and testing laboratories, ensuring GMP compliance and inspection readiness.

Responsibilities

  • Serve as the QA lead for drug product CDMO oversight across manufacturing, testing, packaging, labeling, and release activities.
  • Provide real-time QA support for manufacturing campaigns, including batch disposition, deviation management, laboratory investigations, and change control.
  • Review and approve GMP documents such as master batch records, protocols, reports, and specifications.
  • Oversee and resolve deviations, investigations, CAPAs, and change controls.
  • Act as the primary QA interface with CDMOs to maintain quality oversight and compliance.
  • Participate in vendor selection, qualification, and performance management, including audits and quality agreements.
  • Collaborate cross-functionally with Analytical Development, QC, Manufacturing, Regulatory Affairs, and Supply Chain.
  • Support regulatory inspections and filings to ensure documentation is inspection-ready.
  • Contribute to the development and improvement of quality systems and best practices for external manufacturing.
  • Mentor QA team members and contribute to building a high-performing organization.
  • Support risk management activities to mitigate quality and supply risks.
  • Participate in internal audits and health authority inspections as a subject matter expert.
  • Provide QA support to early-phase programs to ensure scalability and consistency.
  • Support blinded and unblinded clinical supply operations, including review of labeling and packaging controls.
  • Stay current with regulatory requirements and industry trends related to GMP and ICH guidelines.

Requirements

  • Bachelor’s degree in Chemistry, Biochemistry, Pharmaceutical Sciences, or related scientific discipline.
  • 8+ years of experience in the pharmaceutical or biotechnology industry.
  • Significant experience in Quality Assurance.
  • Strong knowledge of FDA, EMA, MHRA, ICH, and global GMP regulations.
  • Experience supporting batch disposition and release activities for clinical products.
  • Proven experience overseeing CDMOs and external manufacturing networks.
  • Working knowledge of EU Qualified Person (QP) certification and batch release requirements.
  • Experience with deviation investigations, laboratory investigations, change control, CAPA management, and risk management.
  • Ability to manage multiple priorities in a fast-paced environment.
  • Ability to travel up to 20–30% domestically and internationally.

Skills

  • Quality Assurance
  • GMP compliance
  • CDMO oversight
  • Batch disposition
  • Deviation management
  • CAPA management
  • Risk management
  • Cross-functional collaboration
  • Leadership and mentoring
  • Problem-solving
  • Communication

Location

  • California
  • Shanghai

Work Type

  • Full-time

Experience Level

  • 8+ years

Education Level

  • Bachelor’s degree

Salary/Compensations

  • $162,000 - $189,000

Benefits

  • Annual performance incentive bonus
  • New hire equity
  • Ongoing performance-based equity
  • Medical insurance
  • Dental insurance
  • Vision insurance
  • 401k match
  • Unlimited PTO
  • Paid holidays including winter shutdown

About the Company

  • Structure Therapeutics develops life‐changing medicines using advanced structure‐based and computational drug discovery technology.
  • The company focuses on chronic diseases with high unmet need, including cardiovascular, metabolic, and pulmonary conditions.
  • Led by international drug innovators and financed by top-tier global life sciences investors.
  • Publicly traded company (IPO February 2023).

Equal Opportunity

  • Structure Therapeutics Inc. is an Equal-Opportunity Employer.